Ace Therapeutics offers comprehensive acute and chronic toxicity assessment services to clients in the field of antipsychotic drug development. Our technical team is highly experienced in toxicology and drug safety evaluation, and is dedicated to providing comprehensive solutions and toxicological data to accelerate the antipsychotic drug development process.
The acute and chronic toxicity assessment service for antipsychotic drugs is a comprehensive safety assessment program designed to evaluate the potential risks associated with drug candidates. This program involves exposing the drug to be tested to experimental animals on a short- or long-term basis.
Our rigorous experimental design and comprehensive toxicity assessment services provide the necessary safety data for the development of antipsychotic drugs.
In acute toxicity testing, we typically utilize in vitro cellular models and animal experiments to assess the immediate toxic effects of potential antipsychotic drugs on biological systems. Our services include measuring the drug's effects on cell viability, cytotoxicity, acute toxicity effects, and behavioral and cosmetic changes in animals. Our acute toxicity data can assist you in making informed decisions in the following areas:
In chronic toxicity assessments, we typically utilize rodents for long-term drug exposure studies. The frequency of exposure is typically once a day, but the frequency of administration and the period of administration may vary depending on the route chosen and can be modified according to the toxicokinetic profile of the drug to be tested. We assess the long-term safety and potential side effects of drugs by examining their effects on body weight changes, organ function, and histopathology in animals.
Ace Therapeutics is dedicated to providing a comprehensive suite of acute and chronic toxicity assessment solutions to assist researchers and developers in understanding the potential risks of their antipsychotic drug candidates and in obtaining the scientific data necessary to support clinical trials and drug launches. If you are interested in our services or require further information, please feel free to contact us.
Enter your E-mail and receive the latest news from us